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Summary: Inhibition of Na+/H+ exchange (NHE) during ischemia reduces
cardiac injury due to reduced reverse mode Na +/Ca2+ exchange. We
hypothesized that activating NHE-1 at buffer pH 8 during ischemia increases
mitochondrial oxidation, Ca2+ overload and reactive O2 species (ROS) levels,
and worsens functional recovery in isolated hearts and that NHE inhibition
reverses these effects. Guinea pig hearts were perfused with buffer at pH 7.4
(control) or pH 8 +/− NHE inhibitor eniporide for 10 min before and for 10
min after 35 min ischemia and then for 110 min with pH 7.4 buffer alone.
Mitochondrial NADH and FAD, [Ca2+], and superoxide were measured by
spectrophotofluorometry. NADH and FAD were more oxidized and cardiac
function was worse throughout reperfusion after pH 8 vs. pH 7.4, Ca 2+
overload was greater at 10 min reperfusion, and superoxide generation was
higher at 30 min reperfusion. The pH 7.4 and eniporide groups exhibited
similar mitochondrial function and cardiac performance was most improved
after pH 7.4+eniporide. Cardiac function on reperfusion after pH 8+eniporide
was better than after pH 8. % infarction was largest after pH 8 and smallest
after pH 7.4+eniporide. Activation of NHE with pH 8 buffer and the
subsequent decline in redox state with greater ROS and Ca 2+ loading underlie
the poor functional recovery after ischemia and reperfusion.
Keywords: energy metabolism, free radicals, ischemia, mitochondria,
reperfusion, Na+/H+ exchange

Cardiac ischemia reperfusion (I/R) injury describes the injury a
heart sustains when deprived of coronary perfusion followed by a
sudden reperfusion. Major factors underlying I/R injury are cytosolic
and mitochondrial (mt) Ca2+ loading and excess generation of reactive
O2 species (ROS).1 The increase in mtCa2+ loading is a result of an I/R
–induced increase in cytosolic Ca2+ loading and occurs largely via the
mitochondrial Ca2+ uniporter (CaU).2 Na+/H+ exchange (NHE) activity
is believed to be minimal under normal pH conditions but increases
with an increase in buffer pH.3 NHE may become activated during
ischemia in response to intracellular acidosis during anaerobic
metabolism, but is especially activated during early reperfusion when
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the transmembrane pH gradient is largest. Inhibition of cytosolic Na+
accumulation induced by activation of NHE, and reduction of excess
cytosolic Ca2+ influx via reverse mode Na+/Ca2+ exchange (NCE), are
the probable mechanisms of acute cardioprotection afforded by NHE
inhibitors.4–6 The relative role of sarcolemmal vs. mitochondrial NHE
(mtNHE) in these events is unknown, but mtCa2+ loading could also
result from mtNHE and mtNCE.7,8 Our objective was to test if buffer pH
–induced activation of NHE is responsible for the subsequent increase
in mtCa2+ overload and how this might lead to mitochondrial as well as
cardiac dysfunction.
In previous reports we showed that blocking the NHE-1 isoform
with eniporide (ENI) improved function and reduced infarct size on
reperfusion after 6 h of no-flow 3°C storage in acidic cardioplegic
solution,9 and that inhibition of NHE was as effective as cardioplegia
alone in reducing cytosolic [Ca2+] after 4 h of cold ischemia.10 We,11
and others,12–14 have also shown that blocking NHE reduced ischemia induced Na+ and Ca2+ overload and improved warm post-ischemic
contractile recovery. The most direct involvement of NHE-1 in I/R
injury comes from a study showing that mice carrying a null mutation
in the Nhe1 gene were protected against I/R injury.15
In previous studies10,11 we measured the effects of blocking NHE
on cytosolic Ca2+ in intact hearts. In the present study our aim was to
assess the effects of augmented NHE by alkalosis on mitochondrial
Ca2+ and energetics in the intact heart during I/R injury and the
reversibility of these effects with inhibition of NHE. We hypothesized
that brief perfusion of hearts at pH 8.0 before and after ischemia
would cause an additional increase in the trans-sarcolemmal proton
gradient, so that cell acidosis during late ischemia and early
reperfusion would augment activation of NHE. In turn NHE would
cause an exaggerated increase in mt[Ca2+] and lead to a more
oxidized redox state (less NADH, more FAD) and an increase in ROS
generation during and after ischemia, thereby contributing to poor
recovery from I/R injury.
We predicted that inhibition of NHE with ENI during I/R-induced
cytosolic Ca2+ and mtCa2+ loading would not only improve myocardial
function and reduce cell death, but also restore the mitochondrial
redox state, reduce mtCa2+ loading and lower ROS production, which
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together contribute to reducing cardiac cell injury. To test this, we
measured myocardial function and tissue damage, and used
fluorescence techniques to assess on-line changes in redox state
(NADH and FAD), mt[Ca2+], and superoxide (O2−•) generation in the
isolated beating heart.

Methods
Langendorff Heart Preparation
The experiments conformed to the Guide for the Care and Use
of Laboratory Animals (US NIH Publication No. 85–23, Revised 1996)
and were approved by the Medical College of Wisconsin Biomedical
Resources Studies Committee. Guinea pigs (n=84) were anesthetized
with ketamine (50 mg/kg, IP) and decapitated. After thoracotomy,
hearts were removed and perfused at 55 mmHg via the aortic root as
described previously11,16–18 with a HEPES buffer solution (gassed with
5% CO2, 95% O2) containing (in mM) 140 Na+, 4.5 K+, 2.5 Ca2+, 1.2
Mg2+, 134 Cl−, 11.5 glucose, 2 pyruvate, 16 mannitol, 0.1 probenecid,
0.05 EDTA, 5U/L insulin, 5 HEPES [4-(2-hydroxyethyl) piperazine-1ethanesulfonic acid N-(2-hydorxyethyl) piperazine-N’-(2ethanesulfonic acid)]) at pH 7.4 and 37°C. Buffer pH 8 was obtained
by titrating CO2 into HEPES buffer as described19 and with 1 M NaOH.
Final buffer [Na+] was 140±2 mM at pH 7.4 and 148±3 mM at pH 8.
HEPES buffer was used to maintain extracellular [Ca2+] constant
during changes in buffer pH because a large increase in buffer pH in
bicarbonate/phosphate buffers causes a large fall in free [Ca2+].19
Buffer [Ca2+] was 2.26±0.02 mM at pH 7.4 and 2.23±0.02 mM at pH
8.
Isovolumetric left ventricular pressure (LVP) and its first
derivatives (dLVP/dtmax, contractility; dLVP/dtmin, relaxation), heart
rate (HR), and coronary flow were measured as described.11,16–18
Coronary arterial (aortic inflow) and coronary venous (right ventricular
outflow) Na+, K+, Ca2+, pCO2, pO2 and pH were measured off-line with
an intermittently self-calibrating analyzer system; venous pO2 was also
measured continuously with an elecrode placed in the coronary
effluent tubing. Cardiac O2 delivery was defined as coronary flow•heart
weight−1•(paO2)•24 µL O2/mL (37°C); cardiac O2 consumption (MVO2)
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as coronary flow•heart weight−1•(paO2-pvO2)•24 µL O2/mL (37°C) at
760 mmHg; cardiac efficiency as developed LVP•HR/MVO2; and %O2
extraction as 100•(paO2 - pvO2)/paO2 (where paO2 and pvO2 are
arterial and venous pO2, respectively).

Measurements of Cardiac Mitochondrial Redox State,
O2−• and [Ca2+]
FAD fluorescence is derived only from mitochondria; the
majority of the NADH signal also arises from mitochondria20–22 and
mitochondria comprise about 1/3 the volume of cardiac myocytes.23,24
The majority of superoxide (O2−•) likely originates from cardiac
mitochondria because its generation in the isolated heart is very
sensitive to mitochondrial inhibitors and insensitive to inhibitors of
xanthine oxidase.25 Myocardial [Ca2+] signals arise from non-cytosolic
sources after quenching by MnCl2;31 the major non-cytosolic source is
the mitochondrial compartment because of its large volume relative to
cell volume.23,24
NADH and FAD, mt[Ca2+], or O2−• was measured near
continuously via a trifurcated fiberoptic probe (3.8 mm2/bundle) placed
directly on the free LV wall using one of four excitation (λex) and
emission (λem) fluorescence wavelengths11,16–18,26 assessed by
spectrophotofluorometery (SLM Instruments Inc, Urbana IL; and
Photon Technology International, London ON) in different subsets of
hearts. Fluorescence light intensity is transmural but attenuated at the
endocardial surface to 20–30% of that at the epicardial surface.27 In a
subset of hearts, as described,16,18,26 10 µM dihydroethidium (DHE)
was loaded for 20 min; at 540 nm λex and 590 nm λem the fluorescence
is primarily a marker of O2−• radicals.28–30 An intermediate product of
DHE is 2-hydroxyethidium, which is labile and fluoresces at a slightly
shorter wavelength.29,30 We speculate that this labile intermediate
forms rapidly, is reversible, and is not necessarily dependent on DNA
chelation to generate the fluorescence signal. In other hearts NADH
autofluorescence (350 nm λex and λem 450/390 nm) and FAD
autofluorescence (480 nm λex and λem 540 nm) were measured near
simultaneously.17,18,26 Alternatively, hearts were loaded with 6 µM indo
1 AM for 30 min; after washout, the cytosolic signal (350 nm λex and
λem 390/450 nm) was quenched with 100 µM MnCl2, which permitted
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measurement of mt[Ca2+].31 mt[Ca2+] was corrected for NADH
autofluorescence during I/R for each group. Calibration of indo 1 for
[Ca2+] was described previously.32 Changing perfusate pH from 7.4 to
8 had no significant effect on Indo 1 fluorescence signal. Each signal
was digitized and recorded at 200 Hz and computed later for mt[Ca2+].
Loading of DHE and indo 1 transiently decreases contractility; washout
restores contractility.

Protocol
There was a time control group and two pH ischemia groups
treated or untreated with 10 µM eniporide (ENI). This concentration
was chosen because ten Hove et al.13 reported that 3 µM eniporide
should block NHE by at least 95%. In each heart either mt[Ca2+], O2−•
or NADH plus FAD were assessed under the same protocol. After
baseline measurement, hearts of the four ischemia groups were
perfused for 10 min either with pH 7.4 (ischemia control), pH 8 alone,
pH 7.4+ENI, or pH 8+ENI. ENI alone did not alter fluorescence
characteristics or spectra of any dye. This was followed by 35 min of
no flow global ischemia induced by clamping the aortic inflow tubing.
After ischemia, hearts were treated in the same manner as before
ischemia for 10 min before reverting to perfusion at pH 7.4 for the
remainder of reperfusion (110 min). At the end of each experiment
hearts were removed and atria discarded; ventricles (1.3±0.2 g) were
cut into 3–4 mm transverse sections and immersed in 0.1% 2,3,5triphenyltetrazolium chloride (TTC) for measurement of infarct size.9–
11,17,18,26

Experiments were also conducted in two additional groups, pH
6.5 and pH 6.5+ENI. Specific results from these studies are only
displayed in Table 1. We observed that pH 6.5 alone or with ENI was
as efficacious as pH 7.4+ENI in protecting mitochondria and improving
functional recovery.
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Statistical Analysis
All data are expressed as mean ±SEM. Statistical differences
were measured by two-way analysis of variance for repeated measures
of a given variable across the four groups at specific time points
(baseline, at 15 and 30 min ischemia, and at 10, 30 and 60 min during
reperfusion). One-way analysis of variance was used to determine
changes over time for a given variable at the same time points. If F
tests were significant (P<0.05), appropriate ad hoc tests (StudentNewman-Keuls or Duncan) were used to compare means (P <0.05;
two-tailed). As in our previous studies,11,18,26 functional recovery and
changes in fluorescent signals at 60 min reperfusion were not
significantly different from those at 120 min reperfusion (not
displayed). Values for NADH, FAD and O2−• are expressed in arbitrary
fluorescence units (afu) and m[Ca2+] in nM. Infarct size was
determined in a blinded manner after 120 min reperfusion.

Results
Mitochondrial Redox State, mt[Ca2+] and ROS
Production
All variables in the time control (i.e., no ischemia) experiments
remained unchanged during the 3 h period of perfusion. Baseline
values for NADH (Fig. 1A) and FAD (Fig. 1B) (redox state) were not
different among groups and did not change before ischemia due to pH
or ENI. At the onset of ischemia NADH abruptly increased by
approximately 17%, while FAD more slowly decreased by
approximately 19%. Note that on reperfusion, NADH levels decreased
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and FAD levels increased, so that by 60 min reperfusion, NADH and
FAD levels, respectively, were farther from basal values in the pH 8
group and more normalized in the pH 7.4+ENI group and pH 7.4 and
pH 8+ENI groups. The biphasic changes in NADH and FAD during
ischemia and reperfusion were not different between the pH 7.4+ENI
and pH 7.4 groups. Acidic buffer (pH 6.5) had similar myocardial
protective effects on NADH and FAD as did pH 7.4+ENI; pH 6.5+ENI
did not improve mitochondrial redox state any better than pH 6.5
alone (Table 1).

Figure 1

Changes in NADH (A) and FAD (B) (autofluorescence units, afu), during

perfusion with HEPES buffer at pH 7.4 (control; n=7), pH 8 (n=7), pH 7.4+eniporide
(ENI, 10 µM) (n=6), or pH 8+ENI (10 µM) (n=6) 10 min before and 10 min after 35
min no flow, global ischemia. A non-ischemia, pH 7.4 time control group (n=4) is also
displayed for all variables. For P <0.05: * pH 8 vs. 7.4; # pH 8+ENI vs. pH 8; † pH
7.4+ENI vs. pH 7.4. Attenuated Na+/H+ exchange by the lower pH and or ENI led to a
less oxidized redox state.

Baseline mt[Ca2+] was not different among groups (Fig. 2A).
Note that toward the end of ischemia, mt[Ca2+] increased in all
groups, but much more so in the pH 8 group than in the pH 7.4 and
ENI treated groups. Compared to the pH 8 group, addition of ENI at
Journal of Cardiovascular Pharmacology, Vol. 52, No. 3 (September 2008): pg. 236-244. DOI. This article is © Lippincott
Williams & Wilkins, Inc. and permission has been granted for this version to appear in e-Publications@Marquette.
Lippincott Williams & Wilkins, Inc. does not grant permission for this article to be further copied/distributed or hosted
elsewhere without the express permission from Lippincott Williams & Wilkins, Inc.

8

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

pH 8 and pH 7.4 attenuated the rise in mt[Ca2+] during late ischemia.
At 10 min reperfusion mt[Ca2+] was significantly elevated in the pH 8
group compared to other groups. mt[Ca2+] was reduced similarly in pH
7.4+ENI and pH 6.5 (Table 1) groups and mt[Ca2+] was higher in the
pH 6.5+ENI group than in the pH 6.5 group at 60 min reperfusion
(Table 1).

Figure 2

Changes in mt[Ca2+] in nM (A) and superoxide (O2−•) in afu (B), during

perfusion with HEPES buffer at pH 7.4 (control; n=8 each variable), pH 8 (n=7 each
variable), pH 7.4+ENI (10 µM) (n=7 each variable), or pH 8+ENI (10 µM) (n=7 each
variable) 10 min before and 10 min after 35 min no flow, global ischemia. For P
<0.05: * pH 8 vs. 7.4; # pH 8+ENI vs. pH 8; † pH 7.4+ENI vs. pH 7.4. Attenuated
Na+/H+ exchange by the lower pH and or ENI led to a smaller increase in mt[Ca2+]
during ischemia and smaller increases in both mt[Ca2+] and O2−• during early
reperfusion.

Baseline O2−• levels (Fig. 2B) were not different among groups.
In late ischemia O2−• levels increased significantly in all groups to
values not significantly different among groups. However, note that
during 10 and 30 min reperfusion, O2−• surged higher in the pH 8
alone group, whereas it fell in all other groups, with pH 7.4+ENI
showing the least increase in O2−• levels at 10 min reperfusion. O2−•
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levels remained significantly elevated during the first 30 min of
reperfusion, but addition of ENI at pH 8 significantly reduced the
reperfusion -induced increase in O2−• production to a level similar to
that in the two pH 7.4 groups. The pH 6.5 and 6.5+ENI groups (Table
1) displayed similarly less O2−• production during reperfusion at a level
equivalent to that of the pH 7.4+ENI group.

Cardiac Function and Infarct Size
Baseline values were not different among groups for developed
LVP (devLVP) (Fig. 3A); diastolic LVP (diaLVP) (Fig. 3B) was set
initially at 0 mmHg. Throughout reperfusion devLVP recovered least in
the pH 8 (11 ± 2 % of baseline after 60 min reperfusion) group
compared to all other groups; recovery was better in the pH 7.4+ENI
(58 ± 7 %) group and intermediate in the pH 8+ENI (42 ± 8 %) and
pH 7.4 (40 ± 4 %) groups. Note that during late ischemia, diaLVP rose
above baseline in all groups and on reperfusion continued to increase
but remained higher in the pH 8 group throughout reperfusion. The pH
7.4+ENI group had the least increase in diaLVP during early
reperfusion and the pH 7.4 and pH 8+ENI groups were intermediate.
The pH 6.5+/− ENI groups exhibited similar increases in devLVP and
decreases in diaLVP during reperfusion (Table 1); these variables were
similar to those of the pH 7.4+ENI group.
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Figure 3

Changes in developed left ventricular pressure (systolic-diastolic LVP or

devLVP in mmHg; A), and diastolic left ventricular pressure (diaLVP in mmHg; B)
during perfusion with HEPES buffer at pH 7.4 (control; n=12), pH 8 (n=12), pH
7.4+ENI (10 µM) (n=12), or pH 8+ENI (10 µM) (n=12) 10 min before and 10 min
after 35 min no flow, global ischemia. For P <0.05: * pH 8 vs. 7.4; # pH 8+ENI vs. pH
8; † pH 7.4+ENI vs. pH 7.4. Attenuated Na+/H+ exchange by the lower pH and or ENI
led to better cardiac muscle function throughout reperfusion.

Functional and metabolic variables did not change over time in
the time control (non ischemia) group (data not shown). Table 2
shows that dLVP/dtmax, dLVP/dtmin and cardiac efficiency recovered
poorly at 10 and 60 min of reperfusion in the pH 8 group compared to
the pH 7.4 group; adding ENI to either pH group improved recovery of
dLVP/dtmax and dLVP/dtmin throughout reperfusion; these variables
were similar among the pH 7.4+ENI and pH 6.5 groups (Table 1).
Cardiac efficiency was slower to recover in all groups (10 min
reperfusion) but remained severely depressed at 60 min reperfusion
only in the pH 8 group. The pH 8+ENI group exhibited improved
recovery of cardiac efficiency compared to the pH 8 group. Heart rate,
O2 consumption, and %O2 extraction were not significantly different
among the pH 7.4 and pH 8 groups on reperfusion.
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Baseline values for coronary flow (Fig. 4A) were not different
among groups. At 60 min reperfusion, flow was higher in pH 7.4+ENI,
pH 8+ENI and both pH 6.5 (Table 1) groups, and lower in 7.4 and pH
8 groups. Similarly O2 delivery was higher in the ENI groups than the
non-ENI groups on reperfusion (Table 2). Infarct size (Fig. 4B) was
smaller in the pH 8+ENI group than in the pH 8 group, not different in
the pH 8+ENI and pH 7.4 groups, and lowest in the pH 7.4+ENI
(31±3%). Infarct size was not significantly different between pH 6.5
(34±2%), pH 6.5+ENI (36±3%).

Figure 4

Changes in coronary flow (A) during perfusion with HEPES buffer at pH

7.4 (control; n=12), pH 8 (n=12), pH 7.4+ENI (10 µM) (n=12), or pH 8+ENI (10 µM)
(n=12) 10 min before and 10 min after 35 min no flow, global ischemia. For P <0.05:
* pH 8 vs. 7.4; # pH 8+ENI vs. pH 8; † pH 7.4+ENI vs. pH 7.4. Infarct size (B) as a
percentage of total ventricular weight measured after 120 min reperfusion. For P
<0.05: * pH 8 vs. 7.4; # pH 8+ENI vs. pH 8; † pH 7.4+ENI vs. pH 7.4. Attenuated
Na+/H+ exchange by ENI at both pH’s led to a higher coronary flow on reperfusion and
less infarction.
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Discussion
Our objective was to activate and block NHE while examining
changes in mitochondrial bioenergetics during I/R when hearts were
perfused just before and after ischemia at pH 6.5, 7.4 or 8. The major
findings are: 1) Brief perfusion of hearts at pH 8 before and after
ischemia caused the most mitochondrial dysfunction. This was
evidenced by the largest mt[Ca2+] overload during and after ischemia,
the most oxidized mitochondrial redox state, and the highest level of
O2−• production during reperfusion. 2) NHE (and NCE) are activated
early during ischemia as suggested by the rapid rise in mt[Ca2+],
particularly in the pH 8 group. 3) Cardiac functional recovery was least
and infarct size was largest in the pH 8 group. 4) Inhibition of NHE by
ENI largely reversed the deleterious mitochondrial and cardiac
functional effects of alkalosis (pH 8 group) on reperfusion.
The improvements in contractility and relaxation in the eniporide
groups were likely due to the lesser damaging effects of Ca2+ overload,
ROS production, and the more reduced redox state. It is likely that the
differences in mtCa2+ overload between the eniporide treated and
untreated groups can be explained in part by the contribution of
sarcolemmal NCE, secondary to NHE, to increase cytosolic Ca2+
loading. NCE and NHE activity in the mitochondrial membrane may
also play a role. The mtCa2+ overload that remained in the eniporide
groups could arise from other cytosolic sources such as enhanced Ca2+
release from the sarcoplasmic reticulum50 due to oxidative stress with
greater passage of Ca2+ into the matrix via the CaU.2
The eniporide-induced improvement in coronary flow on
reperfusion likely stems from less vascular edema and/or improved
endothelial and vascular responsiveness. The higher coronary flow and
better contractility after eniporide treatment may underlie the higher
O2 consumption. These observations clearly demonstrate that
augmented activation of NHE with alkaline pH during I/R results in
even worse cardiac functional recovery and point out the effectiveness
of NHE inhibitors to effectively reverse this dysfunction. Improved
mitochondrial bioenergetics with eniporide treatment may also underlie
the improved cardiac function as discussed below.
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Mitochondrial Ca2+ Loading and Na+/H+ Exchange
NHE is relatively quiescent under non-ischemic conditions at an
extracellular pH of 7.4.33 However, NHE becomes activated during
ischemia when intracellular acidosis ensues, and especially during
early reperfusion when a larger proton gradient develops across the
cell membrane. NHE is both pH and Na+ dependent.34–36 The larger the
transsarcolemmal H+ gradient, the more active is the NHE.37 It was
shown that reperfusion of myocardial tissue at a high pH (7.9)
significantly increased cell Na+ and Ca2+ content but only when NHE
was not inhibited; this indicates the requirement for NHE activity to
indirectly activate NCE.38 Increased NHE activity leads to increased
cytosolic [Na+]11–14 and subsequently cytosolic Ca2+ overload as a
result of activation of the reverse mode of NCE. The increase in
cytosolic [Ca2+]10,11,39 additionally leads to mtCa2+ loading2,18 largely
through the mtCa2+ uniporter (CaU) despite the apparent large
buffering capacity for calcium in mitochondria.
Our study clearly shows that mtCa2+ overload is augmented at a
more alkaline pH during I/R injury but that it can be markedly reduced
when NHE is inhibited with ENI or at pH 6.5. The additional increase in
mt[Ca2+] in the pH 8 group is attributed to the added increase in the
pH gradient across the cell membrane, which results in greater
activation of NHE and reverse mode NCE. Thus, our study
demonstrates that NHE during I/R injury has a consequence not only
to augment cytosolic Ca2+ but also mtCa2+. Moreover, blocking NHE
during and after ischemia reduced this cascade of events that
culminated in mtCa2+ overload and impaired mitochondrial function on
reperfusion.
A previous study reported that in mitochondria isolated after
I/R, NHE inhibition before and after ischemia exhibited improved state
3 respiration and oxidative phosphorylation and decreased mt[Ca2+]
compared to the controls.40 In another study inhibition of NHE with
cariporide in rat cardiomyocytes reduced markers of oxidant –induced
(H2O2) cell death by attenuating cytosolic Na+ and Ca2+ loading and
mtCa2+ loading, and by preventing depolarization of ΔΨm.33 The
present study conducted in intact, beating hearts supports the results
derived previously in isolated mitochondria40 and isolated myocytes33
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that NHE activation and inhibition also alter mtCa2+ and that mtCa2+
loading contribute to the impaired function that occurs with I/R injury.
A small increase in mt[Ca2+] during increased workload is
believed to stimulate the mitochondrial TCA cycle to furnish NADH via
Ca2+-dependent mitochondrial dehydrogenases to match energy
demand with supply. However, a high mt[Ca2+], as observed during
I/R, can impair ATP synthesis and lead to a loss of ionic homeostasis,
opening of the mitochondrial permeability transitional pore (mPTP),
matrix swelling, and outer membrane rupture.33 Irreversible mPTP
opening causes collapse of the ΔΨm and release of cytochrome c to
induce apoptosis.41–44 The collapse of ΔΨm and the subsequent release
of cytochrome c can lead to more ROS production, resulting in the
vicious cycle of further amplification of cellular ROS production,
mtCa2+overload, and increasing cell injury.1,44

Mitochondrial Ca2+ and ROS with Na+/H+ Exchange
Although mtCa2+ loading and formation of ROS are major
causative factors in reperfusion stunning and permanent damage after
ischemia, the cause-effect relationship between mtCa2+ loading and
excess ROS during I/R injury remains unsettled.45,46 Numerous studies
from our laboratory16,18 and others28,47 show that ROS are produced
not only during reperfusion but also during ischemia. Our experiments
may shed some light on whether the initial excess in mtCa2+ leads to
ROS production or increased ROS leads to excess mtCa2+. In each
group we observed similarly reduced redox states and moderate
increases in O2−• during the early ischemic period and an increasingly
oxidized redox state and higher levels of O2−• during the late ischemic
period. However, mt[Ca2+] rose faster and much higher in the pH 8
group compared to other groups. This suggests that an increase in
mt[Ca2+] during ischemia does not directly cause any additional
change in redox state or increase in O2−• level during ischemia.
However, during early reperfusion mt[Ca2+] and O2−• were highest and
redox state was lowest in the pH 8 group. Proportional but smaller
changes occurred in the other groups, so on reperfusion these
variables may all be interrelated. Increased mt[Ca2+] has been
reported to alter the integrity of cytochromes a/a3 in complex IV48 and
to increase nitration of mitochondrial proteins by ONOO−.49 Impaired
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electron flow can result in increased electron leak and excess O2−•
production. Conversely, ROS production may modulate mt[Ca2+] by its
action on cytosolic Ca2+ regulation. H2O2 was shown to modify the thiol
residues of the ryanodine receptor and to stimulate Ca2+ release from
sarcoplasmic reticulum.50 H2O2 at low concentrations may also directly
activate NHE and lead to increased diastolic [Ca2+] in cultured neonatal
myocytes.51,52 ROS was also found to increase activity of NCE in the
reverse mode to increase cytosolic Ca2+ influx.45,53

Mitochondrial Redox State and Na+/H+ Exchange
Redox state (ratio of NADH/NAD and FADH2/FAD) is a
qualitative measure of the reducing equivalents available to drive
respiration. We,17,18 and others,20–22 showed that as the supply of O2
diminishes during early ischemia, electron flux through the ETC falters,
NADH accumulates, and oxidative phosphorylation rapidly declines.54–56
In the present study, the NADH and FAD signals likely represent the
average redox state of a volume of cells underlying the fiberoptic
probe. The marked and irreversible decline in NADH and increase in
FAD during reperfusion in the pH 8 group could represent greater dead
cell volume57 or increased volume of irreversibly oxidized and energydepleted mitochondria.17 The latter seem to be the case in this study
because the continued decline in NADH with the rise in FAD during
reperfusion does not likely represent a reduction in the number of
viable cells. It is interesting that the increasingly more oxidized state
in the pH 8 group during reperfusion correlated with a gradual decline
in the O2−• level. This suggests ROS cannot be produced as the
damaged mitochondria become more oxidized. In contrast, in the pH
8+ENI group and the two pH 7.4 groups, both NADH and FAD returned
nearly to their baseline values on reperfusion, and this was associated
with less O2−• and mtCa2+overload. Thus, the more reduced redox
state during reperfusion implies greater availability of reducing
equivalents and electrons for oxidative phosphorylation along with less
electron leak and normalization of mtCa2+.
Although many studies imply that NHE blockers confer cardiac
protection by reducing cytosolic Ca2+ loading during I/R, the present
study expresses the importance of NHE in inducing additional damage
to mitochondria via mtCa2+ loading. Protecting mitochondria from
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deleterious increases in mt[Ca2+] and ROS is also key to reducing I/R –
induced cell injury. Cardiomyocytes exposed to oxidative stress show
Ca2+-dependent morphological changes in mitochondria such as
swelling and loss of cristae, which is followed by collapse of the ΔΨm,
and finally cytosolic fragmentation.58

Mitochondrial Na+/H+ Exchange
NHE inhibitors may exert their protective effects by a direct
action on mtNHE59 as well as on sarcolemmal NHE, although there is
controversy about the existence of mtNHE-1.39,60 Cariporide, an NHE-1
inhibitor, was shown to block mtNHE and to delay matrix acidification
and ATP depletion during simulated ischemia in cardiac myocytes.8
mtCa2+ uptake by the CaU is largely dependent on the magnitude of
ΔΨm; an increase in mt[H+], which depolarizes ΔΨm, will in turn reduce
mtCa2+ uptake.7,61 In the presence of respiratory inhibitors
(oligomycin, KCN), inhibition of mtNHE was shown to enhance
mitochondrial acidification in permeabilized rat myocytes.7 Therefore,
in our study an added increase in mt[H+] by mtNHE inhibition with ENI
during ischemia may be in part responsible for decreasing mtCa2+
loading via CaU or mtNCE during reperfusion. It is also possible that
the increased transmembrane H+ gradient at pH 8, which lowers
cytosolic [H+], also lowers mitochondrial [H+] by mtNHE. This effect in
turn could increase mt[Ca2+] via the CaU and mtNCE. In recent
preliminary studies,62,63 we showed that eniporide altered matrix cation
balance in isolated mitochondria, which supports the presence of NHE1 in the inner mitochondrial membrane.
Inhibition of NHE may reduce mtCa2+ loading during ischemia by
reducing cytoplasmic [Ca2+] but also by reducing Ca2+ flux through the
ΔΨm –dependent CaU, particularly when ΔΨm is more depolarized by a
higher mt[H+]. Acidification of the mitochondrial matrix reduces proton
influx through complex V (ATP synthase), i.e. uncouples mitochondria,
so NHE inhibitors (or matrix acidosis) may also protect indirectly by
more efficiently restoring oxidative phosphorylation on reperfusion.
Thus on the basis of current knowledge, inhibition of either
sarcolemmal NHE or mtNHE would appear to be beneficial in reducing
mtCa2+ loading. Future studies using CaU blockers and mitochondrial
selective NHE inhibitors may help to delineate the relative importance
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of these exchangers on reducing cytosolic vs. mtCa2+ loading through
the cell and mitochondrial membranes.

Conclusions and Limitations
We have shown that enhanced activation of NHE with pH 8
during ischemia leads to an additional increase in mtCa2+ loading. This
contributes to a greater deterioration of mitochondrial bioenergetics
and ROS production on reperfusion and poor functional return and
greater tissue damage. Blocking NHE with ENI at an alkaline pH
markedly improved functional return on reperfusion by minimizing the
increase in mt[Ca2+], by better preserving the mitochondrial redox
state, and by reducing ROS production. Both sarcolemmal and
mitochondrial NHE may be involved in promoting mtCa2+ loading with
I/R injury.
As in the present study, a large number of experimental studies
have shown beneficial effects by inhibiting NHE during deliberate I/R
injury. Clinical trials of NHE inhibitors, however, have so far failed to
show significant benefits for patients suffering I/R injury. A potential
problem is the NHE inhibitors exhibit their most protective effects
when the drug is given just before ischemia or immediately on
reperfusion.11,64,65 But administration of a NHE inhibitor before
cardioplegic arrest66 also failed to show significant protection in pigs
subjected to cardiopulmonary bypass. Nevertheless, the quite
beneficial cellular effects of avoiding extracellular and mitochondrial
alkalosis during cardiac ischemia and early reperfusion in this model
are clearly reflected by the preservation not only of myocardial
function but also of mitochondrial bioenergetics.
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